The global Infection Control market gathered revenue around USD 41.6 Billion in 2020 and market is set to grow USD 55.9 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 4.9% during the prediction period 2021 to 2027. Growth in the infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections; the increasing number of surgical procedures; the growing geriatric population and increasing incidence of chronic diseases; the growing focus on food sterilization and disinfection; technological advancements in sterilization equipment; and the increasing outsourcing of sterilization services among pharmaceutical companies, hospitals, and medical device manufacturers. The growing number of medical device and pharmaceutical companies in emerging economies, increasing use of E-beam sterilization, re-introduction of ethylene oxide sterilization, and outsourcing operations to emerging countries with an improving healthcare sector will also support the growth of the market in the coming years. Currently, with the surge in cases of COVID-19, there is an increasing focus on personal hygiene and increasing production of medical nonwovens and single-use products, such as face masks and gloves. This, in turn, is expected to propel market growth in the next two years.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Infection Control market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Infection Control market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Infection Control market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America is expected to account for the largest share of the infection control market in 2020
In 2020, North America accounted for the largest share of the infection control market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The region's large share can be attributed to the growing demand for and adoption of sterilization and disinfection products along with services as a result of the rising focus on healthy lifestyles and disease prevention among consumers. The surge in the geriatric population in the coming years and the subsequent increase in the prevalence of chronic diseases, the need for infection control to minimize the prevalence of HAIs, and implementation of favorable government initiatives and stringent regulations on sterilization and disinfection are also propelling the infection control market in the region.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Infection Control Market are:
The prominent players in this market are STERIS plc. (US),Getinge AB (Sweden), Cantel Medical Corporation (US), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), MMM Group (Germany), MATACHANA GROUP (Spain), Sotera Health LLC (US), Ecolab, Inc. (US), Metrex Research Corporation (US), Reckitt Benckiser Group Plc. (UK), Miele Group (Germany), Melag (Germany), and Pal International (UK).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
Global Infection Control Market, by Product & Service
Global Infection Control Market, by End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Infection Control Market, By Product & Service
7.1. Infection Control Market, by Product & Service, 2021-2027
7.1.1. Sterilization Products and Services
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Cleaning and Disinfection Products
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Protective Barriers
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Endoscope Reprocessing Products
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Other Infection Control Products
7.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Infection Control Market, By End User
8.1. Infection Control Market, by End User, 2021-2027
8.1.1. Other Infection Control Products
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Medical Device Companies
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Medical Device Companies
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Life Science Industry
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Food Industry
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Other End Users
8.1.6.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Infection Control Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.1.2. Market Revenue and Forecast, by End User (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.1.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.1.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.2.2. Market Revenue and Forecast, by End User (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.2.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.2.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.2.5.2. Market Revenue and Forecast, by End User (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.2.6.2. Market Revenue and Forecast, by End User (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.3.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.3.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.3.5.2. Market Revenue and Forecast, by End User (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.3.6.2. Market Revenue and Forecast, by End User (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.4.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.4.4.2. Market Revenue and Forecast, by End User (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.4.5.2. Market Revenue and Forecast, by End User (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.4.6.2. Market Revenue and Forecast, by End User (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.5.2. Market Revenue and Forecast, by End User (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.5.3.2. Market Revenue and Forecast, by End User (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product & Service (2016-2027)
9.5.4.2. Market Revenue and Forecast, by End User (2016-2027)
Chapter 10. Company Profiles
10.1. STERIS plc. (US)
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Getinge AB (Sweden)
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Cantel Medical Corporation (US)
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Advanced Sterilization Products (US)
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. 3M Company (US)
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Belimed AG (Switzerland)
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. MMM Group (Germany)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. MATACHANA GROUP (Spain)
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Sotera Health LLC (US)
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Ecolab, Inc. (US)
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms